Vaccines are proving to be highly effective in controlling hospitalization and deaths
associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

Objectives Highly effective vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been developed but variants of concerns are worrisome, especially B …

Since commencement of COVID-19 pandemic, several SARS-CoV-2 variants have emerged
amid containment efforts via vaccination. The Delta variant (B. 1.617. 2), discovered in …

During the COVID-19 pandemic, SARS-CoV-2 variants have emerged and spread
worldwide. The Delta (B. 1.617. 2) variant was first reported in India in October 2020 and …

We are sharing the results of our study which retrospectively looked at the impact of SARS-
CoV-2 delta variant amid coronavirus disease 2019 (COVID-19) ongoing pandemic. Severe …

Over the past 2 years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
caused the coronavirus disease 2019 (COVID-19) and rapidly spread worldwide. In the …

The emergence of SARS-CoV-2 variants may cause resistance at the immunity level against
current vaccines. Some emergent new variants have increased transmissibility, infectivity …

The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants
in different continents is causing a major concern in human global health. These variants …

Several SARS‐CoV‐2 variants have emerged since the pandemic, bringing about a
renewed threat to the public. Delta variant (B. 1.617. 2) was first detected in October 2020 in …

A novel strain of coronavirus, SARS-CoV-2, the causative agent of coronavirus disease
(COVID-19) was first associated with severe acute respiratory disease in late 2019 and has …